| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 5,008,997 | 3,093,862 | ||
| Government contract receivable | 0 | 532,771 | ||
| Prepaid expenses and other current assets | 1,508,251 | 1,508,915 | ||
| Total current assets | 6,517,248 | 5,135,548 | ||
| Total property and equipment | 938,628 | - | ||
| Accumulated depreciation and amortization | 811,568 | - | ||
| Property and equipment, net | 127,060 | 143,862 | ||
| Other assets | 86,947 | 71,010 | ||
| Total assets | 6,731,255 | 5,350,420 | ||
| Accounts payable | 976,411 | 1,830,148 | ||
| Accrued expenses | 847,766 | 699,076 | ||
| Total current liabilities | 1,824,177 | 2,529,224 | ||
| Common stock, .001 par value authorized shares - 150,000,000 issued and outstanding shares 29,705,360 and 10,536,875 at september 30, 2025 and december 31, 2024, respectively | 29,705 | 15,925 | ||
| Additional paid-in capital | 151,279,802 | 142,888,786 | ||
| Accumulated deficit | -146,402,429 | -140,083,515 | ||
| Total stockholders equity | 4,907,078 | 2,821,196 | ||
| Total liabilities and stockholders equity | 6,731,255 | 5,350,420 | ||
GeoVax Labs, Inc. (GOVX)
GeoVax Labs, Inc. (GOVX)